HAGLR and breast carcinoma: Several groups have found that HAGLR is up-regulated in several human cancers (including breast cancer, bladder cancer, lung cancer and neuroblastoma) and the increased expression of HAGLR can promote oncogenesis via inhibition of apoptosis and is associated with the progression and unfavorable prognosis of these cancers [39–43].